Skip to main content

Find Clinical Trials

Home
Conditions
Malignant Lymphomas

Clinical trial condition

Malignant Lymphomas

Explore clinical trials studying Malignant Lymphomas. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Malignant Lymphomas trial results

Completed

Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas

NCT01800630

Conditions: Advanced Solid Malignancies, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: National Cheng Kung University Hospital Tainan, Taiwan

National Taiwan University Hospital Taipei, Taiwan

Taipei Veterans General Hospital Taipei, Taiwan

View Trial Details

Completed

Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

NCT01626547

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chemotherapy-induced Symptomatic Anaemia, +17 more
Locations: Alzey, Germany

Bad Säckigen, Germany

Berlin, Germany

Berlin, Germany

View all 39 locations

View Trial Details

Completed

Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies

NCT01065025

Conditions: Advanced and Incurable Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Universitätsklinikum Essen Essen, Germany

Klinik für Tumorbiologie an der Albert-Ludwigs-Universität Freiburg (KTB) Freiburg im Breisgau, Germany

View Trial Details

Completed

Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor

NCT01212341

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details